KEI submission to the UK IP office consultation on AI and Copyright
Author: James Love
Day 5 of WHO INB 13, negotiations on a pandemic agreement
The text as of February 21, 2025. Proposal_for_WHO_Pandemic_Agreement_E -Onscreen 21 February KEI’s morning intervention: KEI thanks the WHO for approving a 1pm side event, in room W1, where several NGOs will provide reflections on this negotiation. On a different note,… Continue Reading
Day 3 of WHO INB 13, negotiations on a pandemic agreement
Some notes on the informal negotiations on the footnote in Article 11 on the nature of the provisions for transfer of technology in the agreement. Mutually Agreed Process (MAP) With regard to the informal negotiations over the footnote to Article… Continue Reading
Day 2 of WHO INB negotiations on a pandemic agreement.
These are notes from KEI’s February 18 morning intervention: Regarding the footnote to Article 11, on technology transfer, there has been a long standing dispute over the use of words or phrases like voluntary, mutually agreed terms, in the context… Continue Reading
Day 1 of INB13, the WHO negotiations on a pandemic agreement.
Some notes on day 1 of the WHO INB 13 negotiations a pandemic agreement. The Feb 6, 2025 version of the negotiating text is here: 6Feb2025-INB-text This is note from KEI’s morning intervention on the footnote in Article 11 on… Continue Reading
The New NIH Intramural Research Program Access Planning Policy
Introduction In January 2025, the National Institutes of Health (NIH) introduced a new NIH Intramural Research Program Access Planning Policy (“IRP Access Planning Policy” or “Policy”). An NIH web page provides links to several documents describing the policy: https://osp.od.nih.gov/policies/innovation-and-translation#tab1/ The… Continue Reading
Presentation at WIPO Design Law Treaty diplcom side event
KEI Briefing Note 2024:8. The Basic Proposal for the Design Law Treaty (DLT) and its inappropriate restrictions on transparency
KEI Briefing Note 2024:8, The Basic Proposal for the Design Law Treaty (DLT) and its inappropriate restrictions on transparency
KEI Comments to NIH on Exclusive License to T-Cure Biosciences for Anti-KK-LC-1 T Cell Receptors Patents
KEI-NIH-T-Cure-Biosciences22Oct2024 Knowledge Ecology International (KEI) objects to the “Prospective Grant of an Exclusive Patent License: Anti-KK-LC-1 T Cell Receptors” (89 FR 81089) to T-Cure Biosciences, Inc. (T-Cure). Among other things, KEI said the NIH needs to be more forthcoming in… Continue Reading